MA-based Cohere Health secures $50million in equity funding. The funding was led by Deerfield Management, with participation from Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners, and brings the total raised by Cohere to $106 million.
Read also – Krakow-based edrone Secures €4.6 Million in Funding
The latest round of funding will fuel the company’s expansion to meet the increasing demand for Cohere’s intelligent prior authorization platform.
Siva Namasivayam, CEO and co-founder of Cohere said, “The significant growth Cohere has experienced in the last four years demonstrates the high demand we are seeing from health plans and risk-bearing providers to combat antiquated prior authorization processes and to improve patient access and experience, We are seeing even greater traction and growth with both our current portfolio and new clients. From less than 10 individuals in January 2020 to more than 700 employees today, we are thrilled to enter this next growth phase.”
The Centers for Medicare & Medicaid Services Interoperability and Prior Authorization rule, finalized this January, will require health plan investment in advanced technology to ensure compliance with federal prior authorization requirements.
Read also – Amsterdam-based DataSnipper Secures $100Million in Series B Round Funding
Harnessing Cohere’s patented AI-powered technology, Cohere’s solutions assist health plans to meet and exceed these regulations.
Michael Greeley, co-founder and general partner at Flare Capital Partners said, “We are thrilled to add to our investment in Cohere as the company continues its rapid growth, The additional capital will help expedite operations expansion to accommodate the explosive growth, which in turn will further Cohere’s leadership position in the emerging intelligent prior authorization space. Most importantly, this cash infusion will accelerate the company’s ability to help patients get access to the right care faster, and with better outcomes.”
While the use of AI increases the need for accountability, privacy, transparency, and clinical oversight throughout the prior authorization process, Cohere is dedicated to navigating these challenges and revolutionizing the healthcare landscape using responsible and ethical AI with deep clinical expertise to set a higher quality of care.
Read also – Galway-based CitySwift Secures €7Million in Funding
About Cohere Health
Cohere Health is a clinical intelligence company that provides intelligent prior authorization as a springboard to better quality outcomes by aligning physicians and health plans on evidence-based care paths for the patient’s entire care journey. Cohere’s intelligent prior authorization solutions reduce administrative expenses while improving patient outcomes.
Read also – Vilnius-based Practica Capital Secures €80 Million in Funding
